Mexico

11 Vaccines Approved for Use in Mexico

Protein Subunit

Center for Genetic Engineering and Biotechnology (CIGB)

Abdala

Approved in 6 countries
5 trials in 1 country
Approval Source: abcnews.go.com
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: reuters.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: nytimes.com
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
14 trials in 6 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
25 trials in 8 countries
Approval Source: coronavirus.gob.mx
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: gob.mx
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: coronavirus.gob.mx
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
16 trials in 2 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Approval Source: gob.mx
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Approval Source: coronavirus.gob.mx
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: gob.mx

13 in Clinical Trials in Mexico

Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
DNA

Inovio

INO-4800

10 trials in 9 countries
RNA

Walvax

mRNA

4 trials in 3 countries
Non Replicating Viral Vector

CanSino

Ad5-nCoV-IH

Approved in 1 country
5 trials in 4 countries
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
14 trials in 6 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Inactivated

Laboratorio Avi-Mex

Recombinant NDV Vectored Vaccine

2 trials in 1 country
Protein Subunit

West China Hospital

Recombinant (Sf9 cell)

9 trials in 5 countries
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
RNA

Walvax

AWcorna

Approved in 1 country
4 trials in 3 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries

1 Vaccines with Trials in Mexico are No Longer Progressing

RNA

Curevac

CVnCoV

9 trials in 12 countries